title: Antimetabolites.
authors.affiliation: Navy Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: E
authors.initials: E
authors.lastname: Chu
authors.forename: P G
authors.initials: PG
authors.lastname: Johnston
authors.forename: J L
authors.initials: JL
authors.lastname: Grem
authors.forename: C H
authors.initials: CH
authors.lastname: Takimoto
authors.forename: C
authors.initials: C
authors.lastname: Van Groeningen
authors.forename: B A
authors.initials: BA
authors.lastname: Chabner
authors.forename: C J
authors.initials: CJ
authors.lastname: Allegra
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D004351:Drug Resistance; D005472:Fluorouracil / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000493:pharmacokinetics / Q000494:pharmacology; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D015122:Mercaptopurine; D014740:Vidarabine; C024352:fludarabine; D005472:Fluorouracil; D008727:Methotrexate